Continuous Peripheral Nerve Block Catheters Market Size, Share & Trends Analysis Report By Insertion Technique (Ultrasound, Nerve Stimulation, Hybrid), By Indication (Upper Extremity Surgery, Lower Extremity Surgery), By End-User (Hospitals, Ambulatory Surgical Centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Continuous Peripheral Nerve Block Catheters Market Size

The global continuous peripheral nerve block catheters market size was valued at USD 636.03 million in 2025 and is projected to grow from USD 677.12 million in 2026 to USD 1117.26 million by 2034, registering a CAGR of 6.46% during the forecast period from 2026 to 2034. North America dominated the continuous peripheral nerve block catheters market with a market share of 39.4% in 2025.

Continuous Peripheral Nerve Block (CPNB) catheters are medical devices used to provide prolonged pain relief by delivering local anesthetics directly to peripheral nerves. These catheters are placed near a targeted nerve or nerve plexus and connected to an infusion pump that continuously administers anesthetic medication, ensuring sustained pain control.

CPNB catheters are commonly used for post-surgical pain management, particularly in orthopedic and trauma surgeries, as they help reduce opioid dependence, improve patient comfort, and facilitate faster recovery. The global continuous peripheral nerve block catheters market is witnessing substantial growth, driven by the increasing shift toward opioid-free pain management and advancements in catheter technology.

Moreover, the widespread adoption of ultrasound-guided catheter placement is enhancing precision, safety, and efficacy, particularly in orthopedic, trauma, and outpatient surgeries. As surgical volumes continue to rise, particularly in trauma-related cases, the demand for CPNB catheters is expected to grow, further fueling market expansion.

As trauma surgeries continue to rise, hospitals and ambulatory surgical centers are increasingly adopting regional anesthesia techniques, such as continuous peripheral nerve block (CPNB), to improve pain management, shorten hospital stays, and speed up patient recovery. Moreover, the market is benefiting from technological innovations, strategic partnerships, and the development of smart infusion systems, which are shaping the future of pain management in both surgical and non-surgical settings.

Insertion Technique Insights

The ultrasound segment dominates the market due to its real-time imaging capabilities, which enhance precision, safety, and overall procedural accuracy during catheter placement. Ultrasound guidance allows for direct visualization of the needle and surrounding tissues, improving needle positioning and reducing the risk of nerve damage. This technique also ensures optimal anesthetic distribution, making it superior to traditional methods like landmark-based techniques or nerve stimulation, which have higher risks of complications and inaccuracies.

Request Customizationto receive a tailored report.

Indication Insights

Lower extremity surgeries hold the largest market revenue in the global market, driven by the high surgical volume of procedures such as total knee arthroplasty (TKA), hip replacements, and foot and ankle surgeries. CPNB catheters, specifically femoral, sciatic, and popliteal nerve blocks, offer targeted analgesia, significantly reducing opioid consumption and enhancing patient recovery. These benefits, including improved mobility and the ability to discharge patients on the same day, make CPNB the preferred choice for pain management in outpatient settings.

End User Insights

Ambulatory Surgical Centers (ASCs) hold the largest market share thanks to the growing preference for outpatient procedures. ASCs are designed for efficiency, with a focus on minimally invasive surgeries that prioritize patient safety, quick recovery, and cost-effectiveness. These catheters are ideal for providing prolonged pain relief, reducing opioid use, and enabling same-day discharge, which aligns with the ASC model. The increasing demand for outpatient care continues to drive the adoption of CPNB catheters in these settings.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America holds a dominant position in the global continuous peripheral nerve block catheters market with 40.12% market share, driven by the widespread adoption of regional anesthesia techniques and increasing surgical volumes. The region's advanced healthcare infrastructure, strong reimbursement policies, and innovations contribute significantly to market growth.

The rising demand for orthopedic, trauma, and outpatient procedures, combined with the growing emphasis on minimizing opioid use and enhancing patient recovery, accelerates the adoption of CPNB catheters. Moreover, the presence of leading healthcare providers and research institutions further supports the expansion of this market.

• U.S. - The U.S. leads the continuous peripheral nerve block (CPNB) catheters market, driven by significant investments in research and development and the rapid expansion of ASCs. For instance, in July 2023, Adventist Healthcare opened a new ASC specializing in orthopedic procedures, further driving demand for CPNB catheters. The U.S. healthcare system's focus on opioid-free pain management, along with its advanced surgical practices, continues to fuel market growth.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Continuous Peripheral Nerve Block Catheters Market Trends

Asia-Pacific is poised to experience the highest CAGR during the forecast period. This growth is primarily driven by rising surgical volumes, expanding healthcare infrastructure, and the increasing adoption of regional anesthesia. Countries such as China, India, and Japan are investing heavily in the development of hospitals and ASCs, enhancing the accessibility of advanced pain management solutions. Moreover, the growing prevalence of osteoarthritis, trauma cases, and an aging population in the region are fueling the demand for effective postoperative pain management, further accelerating the adoption of CPNB catheters.

• India - India’s CPNB market is expanding rapidly, driven by the growth of healthcare facilities. For example, in August 2024, a new super-specialty surgical building was inaugurated at the Govt. Wenlock Hospital in Mangaluru, improving healthcare infrastructure and expanding access to advanced surgical and pain management solutions, including CPNB catheters. The demand for regional anesthesia techniques is increasing as the country’s population grows and healthcare access improves.
• China - China’s market for continuous peripheral nerve block catheters is expanding rapidly, driven by increasing healthcare investments and growing awareness of regional anesthesia techniques. The country’s high prevalence of osteoarthritis and road accidents further fuel the demand for effective postoperative pain management solutions. As the healthcare sector evolves and more hospitals adopt advanced pain management techniques, the market for CPNB catheters in China continues to gain momentum, addressing both surgical and recovery needs.
• Japan - Japan’s continuous peripheral nerve block catheters industry is witnessing significant growth, driven by the rising number of orthopedic and trauma surgeries. The increasing adoption of regional anesthesia, coupled with the high prevalence of osteoarthritis and hip fractures, is spurring demand for effective pain-related solutions. Moreover, advancements in ultrasound-guided catheter placement and government efforts to promote opioid-free strategies are accelerating market adoption.
• Saudi Arabia – In Saudi Arabia, the market is propelled by rising investments and strategic mergers and acquisitions by key industry players. For example, in July 2023, Solo-Dex, Inc. secured a distribution agreement in Saudi Arabia for its opioid-free acute pain management suite, significantly enhancing access to advanced regional anesthesia solutions. These developments are making CPNB catheters more widely available.

Europe Continuous Peripheral Nerve Block Catheters Market Trends

• Germany - Germany is one of Europe's largest market for continuous peripheral nerve block catheters, supported by a high volume of orthopedic and trauma surgeries and robust reimbursement policies. The rising prevalence of osteoarthritis is further increasing the demand for effective postoperative pain management. Moreover, Germany’s strong emphasis on opioid-free anesthesia techniques and the widespread adoption of ultrasound-guided regional anesthesia contribute significantly.

Company Market Share

Key players in the global continuous peripheral nerve block catheters market are focusing on adopting several key business strategies, such as strategic collaborations, product approvals, acquisitions, and product launches, to strengthen their market presence and expand their customer base. These strategies enable companies to leverage technological advancements, enhance their product portfolios, and improve distribution channels.

Solo-Dex, Inc.: An Emerging Player in the Global Continuous Peripheral Nerve Block Catheters Market

Solo-Dex, Inc. is a growing player in the CPNB market, offering innovative solutions designed to optimize postoperative pain management and facilitate same-day discharge. While its market size is smaller compared to some of the larger, established players, Solo-Dex is actively expanding its footprint in emerging markets, particularly in regions experiencing significant growth in outpatient surgical centers and hospitals.

Recent developments at Solo-Dex, Inc. include:

• In July 2023, Solo-Dex, an innovator in the development, manufacture, and sales of new non-opioid acute pain management solutions, announced a strategic master distribution agreement with CH Trading Group LLC and Farouk, Maamoun Tamer & Co. This historic agreement will introduce the distribution of Solo-Dex's innovative Fascile platform across the Kingdom of Saudi Arabia.

List of Key and Emerging Players in Continuous Peripheral Nerve Block Catheters Market